STAB

Statera Biopharma, Inc. Common Stock

Delisted

STAB was delisted on the 11th of January, 2023.

20 hedge funds and large institutions have $306K invested in Statera Biopharma, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$117K 82,203
LTFS
2
Ladenburg Thalmann Financial Services
Florida
$62K 38,680 -163 -0.4%
VKH
3
Virtu KCG Holdings
New York
$44K 31,144 +14,267 +85%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$32K 22,216 +22,216 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$23K 16,688
Renaissance Technologies
6
Renaissance Technologies
New York
$17K 11,916 +11,916 New
BA
7
BlackRock Advisors
Delaware
$4K 2,800
UBS Group
8
UBS Group
Switzerland
$3K 2,186 +991 +83%
Morgan Stanley
9
Morgan Stanley
New York
$1K 1,050 -200 -16%
IA
10
IFP Advisors
Florida
$1K 775
BFA
11
BlackRock Fund Advisors
California
$1K 741
WA
12
Winfield Associates
Ohio
$1K 500
PRCM
13
Pine River Capital Management
Minnesota
-150,000 Closed
Citadel Advisors
14
Citadel Advisors
Florida
-29,899 Closed
TRCT
15
Tower Research Capital (TRC)
New York
-599 Closed
US Bancorp
16
US Bancorp
Minnesota
$0 100
AG
17
Advisor Group
Arizona
$0 37
AIM
18
Advantage Investment Management
Iowa
$0 25
Deutsche Bank
19
Deutsche Bank
Germany
$0 4
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$0 34
Group One Trading
21
Group One Trading
Illinois
$0 68
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$0 31
Bank of America
23
Bank of America
North Carolina
$0 150 +25 +20%